Cargando…
Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system
BACKGROUND: COVID-19 and influenza (flu) share similar clinical symptoms. Therefore, differential detection of these viruses during the respiratory virus season will be an important component for proper patient triage, management, and treatment. OBJECTIVES: Establish the diagnostic performance relat...
Autores principales: | Paradis, Sonia, Lockamy, Elizabeth, Cooper, Charles K., Young, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Becton, Dickinson and Company. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376527/ https://www.ncbi.nlm.nih.gov/pubmed/34507269 http://dx.doi.org/10.1016/j.jcv.2021.104946 |
Ejemplares similares
-
Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System
por: Yanson, Karen, et al.
Publicado: (2021) -
Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAX(TM) System in asymptomatic individuals
por: Yanson, Karen, et al.
Publicado: (2023) -
Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System
por: Christensen, Katherine, et al.
Publicado: (2022) -
Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric Pathogens
por: Stokes, William, et al.
Publicado: (2019) -
Clinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections
por: Van Der Pol, Barbara, et al.
Publicado: (2021)